{
    "Trade/Device Name(s)": [
        "cobas c 501 Tina-quant Hemoglobin A1cDx Gen.3 assay",
        "HbA1cDx Gen.3",
        "TQ HbA1cDx Gen.3"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "k121610",
    "Predicate Device Reference 510(k) Number(s)": [
        "k121291"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PDJ"
    ],
    "Summary Letter Date": "July 26, 2013",
    "Summary Letter Received Date": "July 29, 2013",
    "Submission Date": "May 31, 2012",
    "Regulation Number(s)": [
        "21CFR862.1373"
    ],
    "Regulation Name(s)": [
        "Hemoglobin A1c Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "Li-Heparin tube",
        "K2-EDTA tube",
        "K3-EDTA tube",
        "KF/Na2-EDTA tube",
        "Na-Heparin tube",
        "NaF/K-Oxalate tube",
        "NaF/Na2-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi cobas c 501 clinical chemistry analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric inhibition immunoassay",
        "Bichromatic measurement"
    ],
    "Methodologies": [
        "Quantitative determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent System"
    ],
    "Document Summary": "FDA 510(k) summary for Roche cobas c 501 Tina-quant HbA1cDx Gen.3 assay for quantitative determination of HbA1c as an aid in diabetes diagnosis and risk assessment.",
    "Indications for Use Summary": "Intended as an aid in diagnosis of diabetes and in identifying patients at risk for developing diabetes, for quantitative determination of hemoglobin A1c in whole blood using the Roche/Hitachi cobas c 501 analyzer.",
    "fda_folder": "Clinical Chemistry"
}